Literature DB >> 15637053

Differential regulation of phosphoglucose isomerase/autocrine motility factor activities by protein kinase CK2 phosphorylation.

Takashi Yanagawa1, Tatsuyoshi Funasaka, Soichi Tsutsumi, Tirza Raz, Nobutada Tanaka, Avraham Raz.   

Abstract

Phosphoglucose isomerase (PGI; EC 5.3.1.9) is a cytosolic housekeeping enzyme of the sugar metabolism pathways that plays a key role in both glycolysis and gluconeogenesis. PGI is a multifunctional dimeric protein that extracellularly acts as a cytokine with properties that include autocrine motility factor (AMF)-eliciting mitogenic, motogenic, and differentiation functions, and PGI has been implicated in tumor progression and metastasis. Little is known of the biochemical regulation of PGI/AMF activities, although it is known that human PGI/AMF is phosphorylated at Ser(185) by protein kinase CK2 (CK2); however, the physiological significance of this phosphorylation is unknown. Thus, by site-directed mutagenesis, we substituted Ser(185) with aspartic acid (S185D) or glutamic acid (S185E), which introduces a negative charge and conformational changes that mimic phosphorylation. A Ser-to-Ala mutant protein (S185A) was generated to abolish phosphorylation. Biochemical analyses revealed that the phosphorylation mutant proteins of PGI exhibited decreased enzymatic activity, whereas the S185A mutant PGI protein retained full enzymatic activity. PGI phosphorylation by CK2 also led to down-regulation of enzymatic activity. Furthermore, CK2 knockdown by RNA interference was associated with up-regulation of cellular PGI enzymatic activity. The three recombinant mutant proteins exhibited indistinguishable cytokine activity and receptor-binding affinities compared with the wild-type protein. In both in vitro and in vivo assays, the wild-type and S185A mutant proteins underwent active species dimerization, whereas both the S185D and S185E mutant proteins also formed tetramers. These results demonstrate that phosphorylation affects the allosteric kinetic properties of the enzyme, resulting in a less active form of PGI, whereas non-phosphorylated protein species retain cytokine activity. The process by which phosphorylation modulates the enzymatic activity of PGI thus has an important implication for the understanding of the biological regulation of this key glucose metabolism-regulating enzyme.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15637053     DOI: 10.1074/jbc.M409457200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

Review 1.  Single-gene disorders: what role could moonlighting enzymes play?

Authors:  Ganesh Sriram; Julian A Martinez; Edward R B McCabe; James C Liao; Katrina M Dipple
Journal:  Am J Hum Genet       Date:  2005-04-22       Impact factor: 11.025

Review 2.  Protein kinase CK2 in breast cancer: the CK2β regulatory subunit takes center stage in epithelial plasticity.

Authors:  Odile Filhol; Sofia Giacosa; Yann Wallez; Claude Cochet
Journal:  Cell Mol Life Sci       Date:  2015-05-20       Impact factor: 9.261

3.  Vascular endothelial growth factor-D is a key molecule that enhances lymphatic metastasis of soft tissue sarcomas.

Authors:  Takashi Yanagawa; Tetsuya Shinozaki; Hideomi Watanabe; Kenichi Saito; Avraham Raz; Kenji Takagishi
Journal:  Exp Cell Res       Date:  2012-02-03       Impact factor: 3.905

4.  Autocrine motility factor modulates EGF-mediated invasion signaling.

Authors:  Dhong Hyo Kho; Tianpeng Zhang; Vitaly Balan; Yi Wang; Seung-Wook Ha; Youming Xie; Avraham Raz
Journal:  Cancer Res       Date:  2014-02-27       Impact factor: 12.701

5.  Hyperthermia reduces migration of osteosarcoma by suppression of autocrine motility factor.

Authors:  Kosei Nakajima; Takashi Yanagawa; Hideomi Watanabe; Kenji Takagishi
Journal:  Oncol Rep       Date:  2012-10-01       Impact factor: 3.906

6.  Complex coordinated extracellular metabolism: Acid phosphatases activate diluted human leukocyte proteins to generate energy flow as NADPH from purine nucleotide ribose.

Authors:  John B Hibbs; Zdenek Vavrin; James E Cox
Journal:  Redox Biol       Date:  2016-02-02       Impact factor: 11.799

7.  Up-regulation of Key Glycolysis Proteins in Cancer Development.

Authors:  Nicole Nowak; Anna Kulma; Jan Gutowicz
Journal:  Open Life Sci       Date:  2018-12-31       Impact factor: 0.938

8.  AMF/PGI-mediated tumorigenesis through MAPK-ERK signaling in endometrial carcinoma.

Authors:  Yiran Li; Yuanhui Jia; Qi Che; Qian Zhou; Kai Wang; Xiao-Ping Wan
Journal:  Oncotarget       Date:  2015-09-22

9.  Oxidation Resistance 1 Modulates Glycolytic Pathways in the Cerebellum via an Interaction with Glucose-6-Phosphate Isomerase.

Authors:  Mattéa J Finelli; Teresa Paramo; Elisabete Pires; Brent J Ryan; Richard Wade-Martins; Philip C Biggin; James McCullagh; Peter L Oliver
Journal:  Mol Neurobiol       Date:  2018-06-15       Impact factor: 5.590

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.